A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1

Autosomal dominant polycystic kidney disease is an important cause of end-stage renal disease, for which there is no proven therapy. Mutations in PKD1 (the gene encoding polycystin-1) are the principal cause of this disease. The disease begins in utero and is slowly progressive, but it is not known whether cystogenesis is an ongoing process during adult life. We now show that inactivation of Pkd1 in mice before postnatal day 13 results in severely cystic kidneys within 3 weeks, whereas inactivation at day 14 and later results in cysts only after 5 months. We found that cellular proliferation was not appreciably higher in cystic specimens than in age-matched controls, but the abrupt change in response to Pkd1 inactivation corresponded to a previously unrecognized brake point during renal growth and significant changes in gene expression. These findings suggest that the effects of Pkd1 inactivation are defined by a developmental switch that signals the end of the terminal renal maturation process. Our studies show that Pkd1 regulates tubular morphology in both developing and adult kidney, but the pathologic consequences of inactivation are defined by the organ's developmental status. These results have important implications for clinical understanding of the disease and therapeutic approaches.

[1]  J. Nicholson,et al.  Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. , 2006, Physiological genomics.

[2]  L. Baert,et al.  Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. , 1978, Kidney international.

[3]  D. Pretorius,et al.  Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant. , 1987, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[4]  Rafael A. Irizarry,et al.  Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .

[5]  J. Calvet Injury and development in polycystic kidney disease. , 1994, Current opinion in nephrology and hypertension.

[6]  Laurie A. Smith,et al.  Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine , 2006, Nature.

[7]  Ralph L Kodell,et al.  Evaluation of Cell Proliferation in Rat Tissues with BrdU, PCNA, Ki-67(MIB-5) Immunohistochemistry and In Situ Hybridization for Histone mRNA , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  S. Somlo,et al.  Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease , 2004, Nature Medicine.

[9]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[10]  Alexander F. Schier,et al.  Planar cell polarity signalling couples cell division and morphogenesis during neurulation , 2006, Nature.

[11]  V. D’Agati,et al.  Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). , 1996, Oncogene.

[12]  R. Sandford,et al.  Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2) , 2004, European Journal of Human Genetics.

[13]  R. Kucherlapati,et al.  Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease , 1998, Cell.

[14]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[15]  E. Avner,et al.  Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. , 2003, Kidney International.

[16]  O. A. Cabello,et al.  Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways , 2005, Nature Genetics.

[17]  M. Kathleen Kerr,et al.  Linear Models for Microarray Data Analysis: Hidden Similarities and Differences , 2003, J. Comput. Biol..

[18]  Weining Lu,et al.  Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation , 1997, Nature Genetics.

[19]  Jean-François Nicolas,et al.  Defective planar cell polarity in polycystic kidney disease , 2006, Nature Genetics.

[20]  E. L. Potter,et al.  PATHOGENESIS OF POLYCYSTIC KIDNEYS. HISTORICAL SURVEY. , 1964, Archives of pathology.

[21]  A. Novick,et al.  The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. De Launoit,et al.  PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. , 2003, Developmental biology.

[23]  K. Blick,et al.  Proliferative activity of cyst epithelium in human renal cystic diseases. , 1995, Journal of the American Society of Nephrology.

[24]  T. Groen,et al.  in Adult Mice Leads to Ob Supplemental Data S 1 Disruption of Intraflagellar Transport esity and Slow-Onset Cystic Kidney Disease , 2022 .

[25]  Jing Zhou,et al.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells , 2003, Nature Genetics.

[26]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[27]  A. Evan,et al.  Cyst formation and growth in autosomal dominant polycystic kidney disease. , 1987, Kidney international.

[28]  O. Heggö A microdissection study of cystic disease of the kidneys in adults. , 1966, The Journal of Pathology and Bacteriology.

[29]  D. Woo,et al.  Apoptosis and loss of renal tissue in polycystic kidney diseases. , 1995, The New England journal of medicine.

[30]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[31]  Meguid El Nahas,et al.  Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  G. Germino,et al.  A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. , 2004, Journal of the American Society of Nephrology : JASN.